These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 923610)

  • 1. The relationship of plasma prolactin to 17-B oestradiol in women with tumours of the breast.
    Jones MK; Ramsay ID; Collins WP; Dyer GI
    Eur J Cancer (1965); 1977 Oct; 13(10):1109-12. PubMed ID: 923610
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum oestradiol-17 beta in women with benign and malignant breast disease.
    England PC; Skinner LG; Cottrell KM; Sellwood RA
    Br J Cancer; 1974 Dec; 30(6):571-6. PubMed ID: 4447785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between plasma progesterone, estradiol and prolactin concentrations and breast cancer in pre and postmenopausal women.
    Raheem SN; Atoum M; Al-Hourani H; Rasheed M; Nimer N; Almuhrib T
    Neoplasma; 2010; 57(1):74-8. PubMed ID: 19895176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum oestradiol-17 beta and prolactin concentrations during the luteal phase in women with benign breast disease.
    Walsh PV; McDicken IW; Bulbrook RD; Moore JW; Taylor WH; George WD
    Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1345-51. PubMed ID: 6542005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex hormones in breast disease.
    England PC; Skinner LG; Cottrell KM; Sellwood RA
    Br J Surg; 1975 Oct; 62(10):806-9. PubMed ID: 1191940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma prolactin in breast cancer.
    Boyns AR; Cole EN; Griffiths K; Roberts MM; Buchan R; Wilson RG; Forrest AP
    Eur J Cancer (1965); 1973 Feb; 9(2):99-102. PubMed ID: 4717492
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum androgen levels and the menstrual cycle in women with benign or malignant breast disease.
    England PC; Sellwood RA; Knyba RE; Irvine JD
    Clin Oncol; 1981 Sep; 7(3):213-9. PubMed ID: 6211319
    [No Abstract]   [Full Text] [Related]  

  • 8. Circulating levels of testosterone, 17 beta-oestradiol, luteinising hormone and prolactin in postmenopausal breast cancer patients.
    Secreto G; Recchione C; Cavalleri A; Miraglia M; Dati V
    Br J Cancer; 1983 Feb; 47(2):269-75. PubMed ID: 6824571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma lipids and prolactin in patients with breast cancer.
    Bani IA; Williams CM; Boulter PS; Dickerson JW
    Br J Cancer; 1986 Sep; 54(3):439-46. PubMed ID: 3756079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of blood prolactin levels in breast diseases using prolactin radioimmunoassay kits (CIS-Prolak Kit)].
    Nakajima K; Saito K; Tobioka M; Ishihara K; Kobayashi T
    Horumon To Rinsho; 1976 Dec; 24(12):1303-10. PubMed ID: 1035518
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pituitary hormone level in breast cancer patients].
    Agranat VZ; Valiura AV; Nikogosian GA
    Med Radiol (Mosk); 1981 Mar; 26(3):3-8. PubMed ID: 6783807
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum oestradiol in women with and without breast disease.
    Bennett IC; McCaffrey JF; McCaffrey E; Wyatt B
    Br J Cancer; 1990 Jan; 61(1):142-6. PubMed ID: 2393409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [L-dopa and prolactin in breast neoplasms and dysplasia].
    Moguilevsky L; Scacchi P; Szwarcfarb B; Barbarelli J; Moguilevsky JA
    Medicina (B Aires); 1978; 38(1):27-30. PubMed ID: 713825
    [No Abstract]   [Full Text] [Related]  

  • 14. Hormonal profiles in lactating and non-lactating women immediately after delivery and their relationship to breast engorgement.
    West CP; McNeilly AS
    Br J Obstet Gynaecol; 1979 Jul; 86(7):501-6. PubMed ID: 476015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum prolactin level in healthy women and patients with functional disorders of the breast].
    Ozieblo L
    Endokrynol Pol; 1977; 28(4):323-30. PubMed ID: 891477
    [No Abstract]   [Full Text] [Related]  

  • 16. Benign breast disease I: hormonal investigation.
    Sitruk-Ware R; Sterkers N; Mauvais-Jarvis P
    Obstet Gynecol; 1979 Apr; 53(4):457-60. PubMed ID: 571588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prolactin. Radioimmunoassay in female breast cancers and benign mastopathies].
    Gorins A; Netter A
    Nouv Presse Med; 1974 Jan; 3(2):73-5. PubMed ID: 4815434
    [No Abstract]   [Full Text] [Related]  

  • 18. Circulating hormone concentrations in women with breast cancer.
    McFadyen IJ; Forrest AP; Prescott RJ; Golder MP; Groom GV; Fahmy DR; Griffiths K
    Lancet; 1976 May; 1(7969):1100-2. PubMed ID: 57508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: Prolactin in benign and malignant breast disease.
    Cole EN; England PC; Sellwood RA; Griffiths K
    J Endocrinol; 1976 Jun; 69(3):49P-50P. PubMed ID: 950543
    [No Abstract]   [Full Text] [Related]  

  • 20. Oestrogen binding and risk factors for breast cancer.
    Ingram DM; Nottage EM; Willcox DL; Roberts A
    Br J Cancer; 1990 Feb; 61(2):303-7. PubMed ID: 2310682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.